Salvia miltiorrhiza (Danshen) Injection Ameliorates Iron Overload-Induced Cardiac Damage in Mice

Abstract

The traditional Chinese medicinal herb Danshen (Salvia miltiorrhiza), first recorded in the “Shen Nongʼs Herbal Classic”, has long been used to treat cardiovascular conditions, although the mechanism(s) underlying its effects remain unclear. Here, an iron dextran injection (50 mg · kg⁻¹ per day) was delivered intraperitoneally to establish a mouse model for investigating the ameliorative effects of Danshen injection (low dose at 3 g · kg⁻¹ per day or high dose at 6 g · kg⁻¹ per day) on iron overload-induced cardiac damage. The iron-chelating agent deferoxamine (100 mg · kg⁻¹ per day) was administered as a positive control. The main constituents of Danshen injection, salvianic acid A (danshensu), protocatechuic aldehyde, and salvianolic acid B, were quantified at concentrations of 2.15, 0.44, and 1.01 mg · mL⁻¹, respectively, using HPLC with UV detection. Danshen injection significantly lowered cardiac iron deposition and the concentration of the lipid oxidation product malondialdehyde, as well as improved cardiac superoxide dismutase and glutathione peroxidase levels in iron-overloaded mice. Serum levels of creatine kinase, creatine kinase isoenzyme, and lactate dehydrogenase in the iron-overloaded mice were significantly elevated (up to ~ 160 %), whereas their activities were downregulated by Danshen injection by 25 ~ 35 % at the high dose and by ~ 20 % at the low dose. Morphological changes of cardiac tissue analyzed by hematoxylin and eosin staining indicated that lesions induced by iron overload could be ameliorated by Danshen injection dose-dependently. Altogether, these results illustrated that the protective effects of Danshen injection were at least in part due to decreased iron deposition and inhibition of lipid peroxidation.

Key words

Salvia miltiorrhiza - Lamiaceae - cardioprotection - antioxidation - HPLC-UV

^* These authors contributed equally to this work.

• References

• 1 Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341: 1986-1995
• 2 Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004; 117: 285-297
• 3 Napier I, Ponka P, Richardson DR. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 2005; 105: 1867-1874
• 4 Omara FO, Blakley BR. Influence of low dietary iron and iron overload on urethan-induced lung tumors in mice. Can J Vet Res 1993; 57: 209-211
• 5 Herbert V. Iron worsens high-cholesterol-related coronary artery disease. Am J Clin Nutr 1994; 60: 299-300
• 6 McCord JM. Effects of positive iron status at a cellular level. Nutr Rev 1996; 54: 85-88
• 7 Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH. Role of L-type Ca²⁺ channels in iron transport and iron-overload cardiomyopathy. J Mol Med (Berl) 2006; 84: 349-364
• 8 Steensma DP, Hoyer JD, Fairbanks VF. Hereditary red blood cell disorders in middle eastern patients. Mayo Clin Proc 2001; 76: 285-293
• 9 Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-1119
• 10 Cecchetti G, Binda A, Piperno A, Nador F, Fargion S, Fiorelli G. Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J 1991; 12: 224-230
• 11 Palka P, Macdonald G, Lange A, Burstow DJ. The role of Doppler left ventricular filling indexes and Doppler tissue echocardiography in the assessment of cardiac involvement in hereditary hemochromatosis. J Am Soc Echocardiogr 2002; 15: 884-890
• 12 Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-761
• 13 Niederau C, Fischer R, Sonnenberg A. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 1256-1262
• 14 Olivieri NF. The beta-thalassemias. N Engl J Med 1999; 341: 99-109
• 15 Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000; 355: 2051-2052
• 16 Galanello R. Iron chelation: new therapies. Semin Hematol 2001; 38: 73-76
• 17 Chaston TB, Richardson DR. Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity. Am J Hematol 2003; 73: 200-210
• 18 Wang G, Wang L, Xiong ZY, Mao B, Li TQ. Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis. Med Sci Monit 2006; 12: SR1-SR7
• 19 Zhao GR, Zhang HM, Ye TX, Xiang ZJ, Yuan YJ, Guo ZX, Zhao LB. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem Toxicol 2008; 46: 73-81
• 20 Yokozawa T, Dong E, Oura H, Kashiwagi H, Nonaka G, Nishioka I. Magnesium lithospermate B suppresses the increase of active oxygen in rats after subtotal nephrectomy. Nephron 1997; 75: 88-93
• 21 Moon CY, Ku CR, Cho YH, Lee EJ. Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis. Biochem Biophys Res Commun 2012; 423: 116-121
• 22 Gambling L, Charania Z, Hannah L, Antipatis C, Lea RG, Mcardle HJ. Effect of iron deficiency on placental cytokine expression and fetal growth in the pregnant rat. Biol Reprod 2002; 66: 516-523
• 23 Link G, Konijn AM, Hershko C. Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells. J Lab Clin Med 1999; 133: 179-188
• 24 Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, DʼArpa D, DʼAnna R, Bongiorno A. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996; 88: 3608-3614
• 25 Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol 2007; 121: 9-22
• 26 Cheng TO. Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease. Int J Cardiol 2006; 113: 437-438
• 27 Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005; 45: 1345-1359
• 28 Wang M, Liu J, Zhou B, Xu R, Tao L, Ji M, Zhu L. Acute and sub-chronic toxicity studies of Danshen injection in Sprague-Dawley rats. J Ethnopharmacol 2012; 141: 96-103
• 29 Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22: 659-661
• 30 Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki H, Kimura I. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther 2008; 117: 280-295
• 31 Zhou R, He LF, Li YJ, Shen Y, Chao RB, Du JR. Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction. J Ethnopharmacol 2012; 139: 440-446
• 32 Link G, Tirosh R, Pinson A, Hershko C. Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction. J Lab Clin Med 1996; 127: 272-278
• 33 Vanella A, Campisi A, di Giacomo C, Sorrenti V, Vanella G, Acqaviva R. Enhanced resistance of adriamycin-treated MCR-5 lung fibroblasts by increased intracellular glutathione peroxidase and extracellular antioxidants. Biochem Mol Med 1997; 62: 36-41
• 34 Saad SY, Najjar TA, Al-Rikabi AC. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 2001; 43: 211-218
• 35 Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, Fleming KA. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med 1998; 339: 417-423
• 36 Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH. Modulation of iron uptake in heart by L-type Ca²⁺ channel modifiers: possible implications in iron overload. Circ Res 1999; 84: 1302-1309
• 37 Benzie IF. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996; 47: 233-261
• 38 Dawson EA, Shave R, George K, Whyte G, Ball D, Gaze D, Collinson P. Cardiac drift during prolonged exercise with echocardiographic evidence of reduced diastolic function of the heart. Eur J Appl Physiol 2005; 94: 305-309
• 39 Chow SN, Wu CC, Huang SC, Tsai YL, Chien CH. Combined analysis of serum lactic dehydrogenase levels and isozyme patterns in ovarian neoplasms. Proc Natl Sci Counc Repub China B 1991; 15: 101-104
• 40 de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 1999; 26: 202-226
• 41 Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-1828
• 42 Fridovich I. Oxygen radicals from acetaldehyde. Free Radic Biol Med 1989; 7: 557-558
• 43 Forman HJ, Dickinson DA. Introduction to serial reviews on 4-hydroxy-2-nonenal as a signaling molecule. Free Radic Biol Med 2004; 37: 594-596
• 44 Huang WM, Yan H, Jin JM, Yu C, Zhang H. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs. Chin Med J (Engl) 1992; 105: 1014-1019